Synthesis and characterization of s-doped graphitic carbon nitride
Chemistry, technology and application of substances · 01.12.2026 · 9 (2) · 32-36
DOI: 10.23939/ctas2026.02.032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry, technology and application of substances, online erschienen am 10.11.2026. Verfasst von Yu. V. Sukhatskyi. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
Graphitic carbon nitride (g-C3N4) doped with S was synthesized by thermal polymerization of a mixture of precursors (melamine and thiourea) with a mass ratio of 1:1. The diffraction pattern of the synthesis product showed peaks of two planes (respectively, (100) and (002)) of the g-C3N4 framework. The shift of the (100) plane peak for S-doped g-C3N4 compared to undoped g-C3N4 towards larger values of the 2θ angle (up to 13.8 °) indicated that the S heteroatoms weakened the stacking interaction of g-C3N4 and the shift of the (002) plane peak towards smaller values of the 2θ angle (up to 27.3 °) indicated a larger interlayer distance in S-doped g-C3N4 compared to native g-C3N4. This demonstrated the successful introduction of S atoms into the g-C3N4 framework. The results of the SEM analysis confirmed the formation of a layered porous structure of S-doped g-C3N4, which is important for increasing the photocatalytic activity of the material.
Zitieren
APA
Sukhatskyi, Y. V. (2026). Synthesis and characterization of s-doped graphitic carbon nitride. Chemistry, technology and application of substances, 9(2), 32-36. https://doi.org/10.23939/ctas2026.02.032
Vancouver
Sukhatskyi YV. Synthesis and characterization of s-doped graphitic carbon nitride. Chemistry, technology and application of substances. 2026;9(2):32-36. doi:10.23939/ctas2026.02.032
BibTeX
@article{Sukhatskyi2026,
author = {Sukhatskyi, Yu. V.},
title = {Synthesis and characterization of s-doped graphitic carbon nitride},
journal = {Chemistry, technology and application of substances},
year = {2026},
volume = {9},
number = {2},
pages = {32--36},
doi = {10.23939/ctas2026.02.032}
}
EUVIMED